July 19, 2019 – (DURHAM, NC) – MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and asymmetric hearing loss (AHL). This is the first and only time that cochlear implants have been approved for these indications in the United States.
Read the official press release here.
MED-EL USA announces two programs for new recipients in the USA or Canada.
Read the full press release here.
Cochlear announces the launch of the Nucleus® Profile Plus Series implant, designed for routine 1.5 and 3 Tesla magnetic resonance imaging scans without the need to remove the internal magnet.
Initial availability is in Germany, appearing in other markets pending regulatory approval.
With this announcement, all three major cochlear implant manufacturers offer up to 3T MRI compatibility without removal of the internal magnet. More information on the differences between options will be forthcoming.
The Naída CI Connect is available now for ordering in the United States. This small boot slides onto the bottom of the Powercel 170 battery, and enables direct Bluetooth streaming from nearly all Bluetooth 4.2 devices and older phones. With the Naída CI Connect, you can hear the phone ring in your processor, and answer the phone by pressing the button on the bottom. There is no need to take the phone out – the microphones on the Naída CI Connect become your phone microphones. Truly hands-free calling with any phone!
You can also use the Naída CI Connect to stream sound from a Bluetooth device directly. And with the TV Connector, you can stream sound to both processors if you have two Naída CI Connects. You can get a Naída CI Connect and a TV Connector for $409 from Advanced Bionics today!
Advanced Bionics announces US availability of the Chorus processor for C1.0 and C1.2 recipients. Chorus offers several great features for recipients of these legacy implants, including:
Learn more at Advanced Bionics!
Canada Health has approved the SONNET 2 and SONNET 2 EAS processors for MED-EL. Stay tuned for more information as it becomes available!
Cochlear Limited today announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.
Editor’s note: Clinical trials provide no guarantee that a product will be available in a given time frame, or even at all. If you are considering a cochlear implant and have questions about potential future developments, please discuss them with your hearing professional.
The Nucleus® 7 sound processor is now available for recipients with CI24M and CI24R implants. Ask your audiologist for details!
MED-EL announced today the US Food and Drug Administration (FDA) approval of the RONDO 2 cochlear implant audio processor. Just place the RONDO 2 on the charge pad and it will charge automatically without wires or cables. The rechargeable battery provides up to 18 hours of battery life, and recharges after four hours.
Product availability is estimated in Fall 2018. For more information, read the press release here.
MED-EL is offering new US recipients a voucher for a free RONDO 2, which can be exchanged for the processor when it becomes available, estimated Fall 2018.
cochlear implant HELP 
